Literature DB >> 603968

New cephalosporin derivatives with high antibacterial activities.

M Ochiai, O Aki, A Morimoto, T Okada, Y Matsushita.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 603968     DOI： 10.1248/cpb.25.3115

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN： 0009-2363            Impact factor:   1.645


× No keyword cloud information.
  6 in total

1.  Intramuscular and intravenous pharmacokinetics of cefmenoxime, a new broad-spectrum cephalosporin, in healthy subjects.

Authors:  G R Granneman; L T Sennello; F J Steinberg; R C Sonders
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

2.  Ro 13-9904, a long-acting broad-spectrum cephalosporin: in vitro and in vivo studies.

Authors:  P Angehrn; P J Probst; R Reiner; R L Then
Journal:  Antimicrob Agents Chemother       Date:  1980-12       Impact factor: 5.191

3.  Cefmenoxime (SCE-1365), a novel broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities.

Authors:  K Tsuchiya; M Kondo; M Kida; M Nakao; T Iwahi; T Nishi; Y Noji; M Takeuchi; Y Nozaki
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

4.  Metabolic fate of SCE-1365, a new broad-spectrum cephalosporin, after parenteral administration to rats and dogs.

Authors:  S Tanayama; K Yoshida; K Adachi; T Kondo
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

5.  Lack of relevance of kinetic parameters for exocellular DD-peptidases to cephalosporin MICs.

Authors:  D B Boyd; J L Ott
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

6.  GR 20263, a new broad-spectrum cephalosporin with anti-pseudomonal activity.

Authors:  C H O'Callaghan; P Acred; P B Harper; D M Ryan; S M Kirby; S M Harding
Journal:  Antimicrob Agents Chemother       Date:  1980-05       Impact factor: 5.191
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.